Exploding Topics
Trending Startups
Top Websites
Get Advanced Insights on Any Topic
Discover Trends 12+ Months Before Everyone Else
How We Find Trends Before They Take Off
Exploding Topics’ advanced algorithm monitors millions of unstructured data points to spot trends early on.

Features
Keyword Research
Performance Tracking
Competitor Intelligence
Find Your Site’s SEO Issues in 30 Seconds
Find technical issues blocking search visibility. Get prioritized, actionable fixes in seconds.
Powered by data from
Tesamorelin
This synthetic peptide is utilized to decrease excess abdominal fat in HIV-infected patients with lipodystrophy by promoting growth hormone production. It is marketed under the brand name Egrifta and is distinguished by its specific application in managing lipodystrophy associated with HIV. The primary beneficiaries of this treatment are HIV-infected individuals experiencing lipodystrophy-related abdominal fat accumulation.
Tesamorelin was discovered on April 30th 2025 and it currently has a search volume of 22.2K with a growth of +99X+.
Growth
- Exploding
- Regular
- Peaked
Speed
- Exponential
- Constant
- Stationary
Seasonality
- High
- Medium
- Low
Volatility
- High
- Average
- Low
Save this topic and build your own trend dashboard.
Available with Exploding Topics Pro, try it now.
1.1M+ trends in our growing database.